<VariationArchive VariationID="15061" VariationName="NC_000011.10:g.5226570_5233984del" VariationType="Deletion" Accession="VCV000015061" Version="5" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="2" DateLastUpdated="2024-05-12" DateCreated="2017-01-13" MostRecentSubmission="2023-10-07">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="30100" VariationID="15061">
      <GeneList>
        <Gene Symbol="HBB" FullName="hemoglobin subunit beta" GeneID="3043" HGNC_ID="HGNC:4827" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>11p15.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="5225464" stop="5227071" display_start="5225464" display_stop="5227071" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="5246695" stop="5248300" display_start="5246695" display_stop="5248300" Strand="-" />
          </Location>
          <OMIM>141900</OMIM>
        </Gene>
        <Gene Symbol="HBD" FullName="hemoglobin subunit delta" GeneID="3045" HGNC_ID="HGNC:4829" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>11p15.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="5232838" stop="5234483" display_start="5232838" display_stop="5234483" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="5254058" stop="5255857" display_start="5254058" display_stop="5255857" Strand="-" />
          </Location>
          <OMIM>142000</OMIM>
        </Gene>
        <Gene Symbol="LOC106099062" FullName="HBB recombination region" GeneID="106099062" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>11p15.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="5226570" stop="5228834" display_start="5226570" display_stop="5228834" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC106099063" FullName="HBD recombination region" GeneID="106099063" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>11p15.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="5233984" stop="5234365" display_start="5233984" display_stop="5234365" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC107133510" FullName="origin of replication at HBB" GeneID="107133510" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>11p15.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="5222166" stop="5229620" display_start="5222166" display_stop="5229620" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC110006319" FullName="beta-globin gene 3' regulatory region" GeneID="110006319" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>11p15.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="5223780" stop="5226590" display_start="5223780" display_stop="5226590" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NC_000011.10:g.5226570_5233984del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11p15.4</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="5226570" stop="5233984" display_start="5226570" display_stop="5233984" variantLength="7415" positionVCF="5226569" referenceAlleleVCF="AGACTCACCCTGAAGTTCTCAGGATCCACGTGCAGCTTGTCACAGTGCAGCTCACTCAGTGTGGCAAAGGTGCCCTTGAGGTTGTCCAGGTGAGCCAGGCCATCACTAAAGGCACCGAGCACTTTCTTGCCATGAGCCTTCACCTTAGGGTTGCCCATAACAGCATCAGGAGTGGACAGATCCCCAAAGGACTCAAAGAACCTCTGGGTCCAAGGGTAGACCACCAGCAGCCTAAGGGTGGGAAAATAGACCAATAGGCAGAGAGAGTCAGTGCCTATCAGAAACCCAAGAGTCTTCTCTGTCTCCACATGCCCAGTTTCTATTGGTCTCCTTAAACCTGTCTTGTAACCTTGATACCAACCTGCCCAGGGCCTCACCACCAACTTCATCCACGTTCACCTTGCCCCACAGGGCAGTAACGGCAGACTTCTCCTCAGGAGTCAGATGCACCATGGTGTCTGTTTGAGGTTGCTAGTGAACACAGTTGTGTCAGAAGCAAATGTAAGCAATAGATGGCTCTGCCCTGACTTTTATGCCCAGCCCTGGCTCCTGCCCTCCCTGCTCCTGGGAGTAGATTGGCCAACCCTAGGGTGTGGCTCCACAGGGTGAGGTCTAAGTGATGACAGCCGTACCTGTCCTTGGCTCTTCTGGCACTGGCTTAGGAGTTGGACTTCAAACCCTCAGCCCTCCCTCTAAGATATATCTCTTGGCCCCATACCATCAGTACAAATTGCTACTAAAAACATCCTCCTTTGCAAGTGTATTTACGTAATATTTGGAATCACAGCTTGGTAAGCATATTGAAGATCGTTTTCCCAATTTTCTTATTACACAAATAAGAAGTTGATGCACTAAAAGTGGAAGAGTTTTGTCTACCATAATTCAGCTTTGGGATATGTAGATGGATCTCTTCCTGCGTCTCCAGAATATGCAAAATACTTACAGGACAGAATGGATGAAAACTCTACCTCGGTTCTAAGCATATCTTCTCCTTATTTGGATTAAAACCTTCTGGTAAGAAAAGAAAAAATATATATATATATGTGTGTATATATACACACATACATATACATATATATGCATTCATTTGTTGTTGTTTTTCTTAATTTGCTCATGCATGCTAATAAATTATGTCTAAAAATAGAATAAATACAAATCAATGTGCTCTGTGCATTAGTTACTTATTAGGTTTTGGGAAACAAGAGATAAAAAACTAGAGACCTCTTAATGCAGTCAAAAATACAAATAAATAAAAAGTCACTTACAACCCAAAGTGTGACTATCAATGGGGTAATCAGTGGTGTCAAATAGGAGGTTAACTGGGGACATCTAACTGTTTCTGCCTGGACTAATCTGCAAGAGTGTCTGGGGGAACAAAAAGCCTCTGTGACTTAGAAAGTAGGGGTAGGAGGGGAAAAGGTCTTCTACTTGGCTCAGATTATTTTTTTCCTCTAGTCCACTAAGAATACTGCGTTTTAAAATCATTTCCTTGATTCAAGTTCCTATTTCTCTTTATATTTTGTTTGTTTAAACCTCCTTTACTAAAATTTACTCTTCTTTCTCTATAGCTTCCCAACGTGATCGCCTTTCTCCCATCCCCCTGTACTTTTTCCCCTTGTACTAAATTAACTCCTCAGGTGAGGAAAAACTTTTGAAGTGCAGAGTTCTGCTTCCTGCTATTAAAAGATGTAATTAAAACAGCAAAGGTAGCAAGCATTTATGAGGTCAGCGTAGGGTCTCAGTGTTCCCTAAGGGCCCTGTCAGTCATCCTGAATCCTGCCCCTACCTGGAAACCCATGTCGGTTTAGTAAGGAAAGTGTTATACTTTTACTTTGCATGTTTCTCCTACTTCTTCCTTTCAGCTCTAACACTCTGAAACTACGATTACACAAAATAAAATAAAATAAAATAAAATAAAACAATAAAATGAAATAAAATTTAGGTTAACCAAAAGAAACTGGATCCTCTATTTCTAGTTATCAGAAGGAAATTTACAAATTTCTTATTTCCATTGCTTTATTCTCTTAAATGCTTTCTCTATTATTGCTAAATAAATAGAGATCTCTCACTTTTTCTACCTGTCTCAACCCTCATCAGGTACTTGTGAAAAAATCTCACTCTGATTATTCTCACACACGCAGAAAGTGTTTGGTTCTTCTATGGCTATCTGGAGCCTAGGTTAAAAAATTATGCCTATGTATGATTATAGAGGTAAGAGGGATAAAATTTAAGTATTTTCTTTTTATATTCATTCCTCTGTAAAAAACTAAAGCAATGAGGATCTAGGCACACGTGTATCCCTGAGAAAAGATTTCACATGTTGAATCCTGGGAAAAGACGTCTTTAAAATATTTTAAATGTTAAAACATGCAGATTTGACTTGGCTGTTAGATTTTGGATTTTATTTTATTAAATTTAAACCTGCATTAGCATTGTTTTAGATTTAGACAGTTTTCAAGACCCTGTTTCACATCCCTGATATAAGAGGCATGTATATGTGAAATAAAGTGTTCTGCGGAAGTTTGAATATGTCTTTTGCAAATATCCTGGGTCAAAGAAAATGCACAGACTTTATGAAATTATAATATAGGTTATATTTATAGTATTCTGAAAGACCAAAATTGTCAAAGCAAGAGCTTTGAAATCCTGATTGGCAGAAATTGTCACCTTCTTAAAGACTTACCCTACAACTTCTTATGCTCAGAAATAGTTTTCCTTTTTCTATTTTGTTTTCTTTTTTAAATGATGAACTATGGATCCTTCTCTTGTGTTGGCAACTGCTGCAGATACCATCATCCTGGCTTCAAGGCAGGGGTTGCTTTTCCAATGGTAGTTACTTAGTGTGACTAGAGTGTAACGCAGACTTTTCTTTCTATTACCCATAATACCCTGCAGGGACAAGGCTGCAAGCTATACTAAGACCATCAAAAGCCCAGGCATACCAGGCAAATAAGTTTCAAGAAGCAATAAATAGTGCAAATTTGGTTATGGTCAGAGCCTCAGTTTCAAATCTAAATCAGCATTCAAAGTTCCTGAAAAACTATTCAAGCTTACTGACATCTTCACTATTGTGAGCTTGCTTCTACTCTGTGAATGGATGCCACAGCAGGTGCAGGTCTATTCTACTTTTATTCCAGCCCCACTGACCACAACACACACACACACACACACACACACACACACACAAGTCCTCAAAAAAGAGACAGCGAGAGAGACAGAGGTCCATTTCCTTTACTCCAGTCTATTAATCTTTCTTAAGTCCTAATGTTTTATATCAGAATGGCCCTAGTCTGGGTATACTTAGAGGATGAATATTAACTTCCTCCATGAAAATCATGACACTCATCTATGGGAGTGTGGTTTTATCATTTGTTTCAAAAGCAGCACTTGACTAGAGTATTTTTATACATGCTCTACTGTTTAGTCTAAAATTCCCCAAGTGAGACATTTTAGCAATCTACTGTATATGTTCCTAGGTCAAGCACAGTCTAGCTACTTGCTACAGACTTCTCTCGCAGATACACAATCTCTCAGTAAACACAACTCAGCAGCTCTCAGAATTAATTAATTAAAATGAAATAAAAATGCTCCAAGAAAACCAGAACCCATAGAAACAAACCGCACACACACAAAATAGTTTGGAAATAGGATAGTTTAGTTCACTTTAAAAAGTTGTATTTCTTACCAAAAAGCAATAAAGTCAACATAGACAGAACTTTGCTAAAGTATATGCATAATTATTACAGAAAAATTTATATTTCAGTCTGCACCTTGTTCATTAATATTTCCTCCACTGGGCTCAGATTTTCATTCAGAATTAGCTTTTTTTTAACCTCATTAAGTGGGCCATGGTGTCAATTTATGGAGAGCAGAGGTACAGTCTTCAGATAAATTTGAGATTGCATCTCTTTAGAGGTAGAATCTTGGCTTCAGTCTGAACACCCTTTACAAACATGTAGGCATTAATTCAGAGGACTGCTCTGAAGCTCAAGAGATGGATGATTTAGGAGACTATTAGGCTTAATTCTCCTGACATTAAATTATTTTATTGAAAAATTTTCATGAACTCAAATTCACATTATTACGTCCTCTCTTCCCTTCCTCTCTCCCTCTCTTTCACACACACACACACCCTTTCATTCAGACATACTGAACATAGTTTATAAAGCAACGCCATAGTGAGAAAAGAAAAACAACCATTTGATAAATTATCAAATAAAATTAAAGCCAAATCTTGAGGAATTAATTCCATTCCTATACTTTGTTTTAACTTTCATTTTAAATTTGGGGGTACATGTACAAGTTATATAGGTAAATTGCATATCACTGGGTCTTGATGTACAGATTATTTCATCACTCAGTGATGAACTTAATACCCAATAGGTTCTTTTTCATCGTCTCCCTCTTCCCACCCTCAACCCTCAAGTAGGCCTGGGTGTCTGTTGATCTATTTTTTGTGTCCATGTGTATCATCATTTAGCTCCCACACTCCTAGACTCTTACAAAAGCTCTACTCTAACAAATAATTTTAATATAACAACAAGGTGCCAAGTCTTTTTTCATCTCTTGACCTCCTCATCTTCAATATGAAGATAGCAATGCCTAGCATATAGTAATTGTGTGTGCTCGGCACATGTCCCATCCAGGTGATGTTCTCATGAATTCTCTGGTATTTGGATTTTTAGGGCCAACATCTTGCCTAGACTCACTGACTACTTCTAATGGTGTAGGAATAGAAGGTATAGTAAGCTATATTTGCTCTTTTTTTTTGACTTTTGGAGAAAGGAATGTAGTTTGTTTTCCCTATCAAGATCATAAGGTCTACAATCTCTCTTACTGTCTTTCGAATACCACACAAGTATCTCCTTTTAATATCTTACTCTTATGAGAACTTCCCTATGCTCAGGAATGTGAAAGTGATCTTCCCCAAAATGCCCTGAGTAGCTCTGCTTCTGATATGTAAACCAGTGGTTCCTAAATATCTTATTCAGATATAAAGAGTTCTCAGTGCCTACTATGTATAATGACTTAAGGAAAACACATGGATATAAAAGAGCTTCTGCTGCCAGTCAATTCAAAATGTTGTGATCAAAACAGTTAACTATAACACATTGTCAGTATATTCTGGCAGTACAGACAGAGTTACTGTGAAAGCACTTTCAAACACAAGGAAACAACAGATTCTGTTTAGGTATTCAAGTAAGTTTAAAATTAATCAACATGCATATAATACAGATTTTTAAAAATGTATACAACTGAGAAAGTTCTAAAAATCCTTCTAATTTTACCTATGGCAAAAATGGTGCTCAAGGAAAAAAATATTACTCCTATGATCAGAAAGGAAATAACTGTTCGGTTGTTTACTGCATGCTTCCTCTTTGTATGTTGTAGCATTAACAACAAAGAAACACTGTGCGATGGTATTATTAATATTGTCCTCTAATTCCAGAAGTTCTAAAGCAAGGAATAATCATTCCTTCATTTACTCATTTACTCATTCGTTCATTCATTCACTGTTTTCTTGAATAAATATTTTCTTTCTGCCCATTGATGAATTTAATATGAGGCACAGTAGGCATGTAAGAAGGTAGAGAATAGGCAGAATTGCTTATAAAGCACGGAGTGTGTGTGTGTGCATGAAATAAATAAGAAAAATATAAAAATATAAAAAATGGTGTGGGGGAGGGTTTGGAAAGATTTTTTGGGTAGTATAGAGAAGTTTATTGTGGCTGGGGTCAAGAGAGGTCACAAGTAATACGTGAGCAATGAATCTTGACTGAAATATGGGAAGATAAGAGGAAATTCTTTACAGAGATGTTCTGGGGCAAGTAAGAGGAGGAAGCTATTTCTTGGAGCAGGAACACTTGATGGGGTATAGTATTATGGGCTACAATGTGCAGGCAAAGGAAGGAGGAAGAAAGACAACATAACATTGTCTTGAGTAATCATTATGCCTTTAATTGAGCACATTATTTTCTCAGTAATTGTTGGAGTTTAATCGTAGCATTACCCTTGAGGCTATGTCTTAGGGTTGAGGTCTTCCCTAGAACCTCTGCAGTGCCAGTATTATCTTTGTATCAAGAGTTCTTGATAATTTCTGCTCTTTGGAGGTAGAAGTGTCACCCATTAATGCCTTGTACGGTTCCCTTGCTTTTCTCTTTTCCCATGTACTCTTTGTAAAATAAACAAGTGCTCCCTATCTGTAGAGCCTCAGGAACCTTCTTACACACCTGGACAAAAAAATGAAATAAGTGAAATTAATCAGGAAGTTGAGCTGAACATTCTTTATTAGGCAGAAGCCATACCCTTGAAGTAGGCATTGTGTTCCCAAGTTCAGAAAATAGAATCTAGGGAAATAGGGTCTTCTTATGGTTATCAGGAAACAGTCCAGGATCTCAATGGTACTTGTGAGCCAGGGCATTAGCCACACCAGCCACCACCTTCTGATAGGCAGCCTGCATTTGTGGGGTGAATTCCTTGCCAAAGTTGCGGGCCAGCACACACACCAGCACATTGCCCAAGAGCTGCGGAGAAGAGGTAGGCAGATACATGCATATGGTTAACAGAGAAATAAAGACTGGCTTCTGAGAAACTGAGCCAACACCCATTTTTTTCTGCCCAAATCTTAGACAAAACTGATCCCCAGGTTATTCCCATCAGCATAAATAAGTACATATATGAATGCATACATATAACATATATCTATACACACACATCCTCTATGTACTTAACTAGCATGTAGTCTATATATGTACATATATGCTATATATGCTGTATAATACTATATACAAATTAATTCCAAATTAGTTTTAATTTTGTATGTGTATATAGCATATACAAATTAATTACTATAAACAGATTAATAGATACAAATTAATTGATTAATCAGTGTGATGATGGGCTGTCTCCTAGCAACGACTTCTGCCCCACCTCCAGTGTAACTGCCTAGTCTTTCATAATCAAATATTCACTTTCCTTTCCATTCCATTTACTACAGAATTTATAAAATTCCAATTATTCCTTATTGTAAAATGATTTATAGCCTCTAAAACAGTATTCTATGCCTCTCATCTTTGAGTTGGAGCCTCTCCCATACCCATGTGGAGAGACAAAAGGATTATTCTAAGTGCAGAATTAGCAGGTGAGAGCTGGTATGCATAATTTGAGTTGTTGTTAGAGAAGGAAAAATGAAGGGAGGGGGTTGGGAGAGAAAGACAGGATATTAAATAATTTAAAATAGCAAGATTGTGAGGAAGGAAAAAATGCAGAATATTTAAATAAAAAATTAACAAAATTTTAGAAGCATTAAATGATAAAATATAGTAAAATGACAAAAATGTGGGAGAAGAGCAGGTAGGTAAAAGAACCAAAATGTAAGATTAGAAAGTAAAAAGAGAAAAGTGAAGCATCTCCTGG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="5247800" stop="5255214" display_start="5247800" display_stop="5255214" variantLength="7415" positionVCF="5247799" referenceAlleleVCF="AGACTCACCCTGAAGTTCTCAGGATCCACGTGCAGCTTGTCACAGTGCAGCTCACTCAGTGTGGCAAAGGTGCCCTTGAGGTTGTCCAGGTGAGCCAGGCCATCACTAAAGGCACCGAGCACTTTCTTGCCATGAGCCTTCACCTTAGGGTTGCCCATAACAGCATCAGGAGTGGACAGATCCCCAAAGGACTCAAAGAACCTCTGGGTCCAAGGGTAGACCACCAGCAGCCTAAGGGTGGGAAAATAGACCAATAGGCAGAGAGAGTCAGTGCCTATCAGAAACCCAAGAGTCTTCTCTGTCTCCACATGCCCAGTTTCTATTGGTCTCCTTAAACCTGTCTTGTAACCTTGATACCAACCTGCCCAGGGCCTCACCACCAACTTCATCCACGTTCACCTTGCCCCACAGGGCAGTAACGGCAGACTTCTCCTCAGGAGTCAGATGCACCATGGTGTCTGTTTGAGGTTGCTAGTGAACACAGTTGTGTCAGAAGCAAATGTAAGCAATAGATGGCTCTGCCCTGACTTTTATGCCCAGCCCTGGCTCCTGCCCTCCCTGCTCCTGGGAGTAGATTGGCCAACCCTAGGGTGTGGCTCCACAGGGTGAGGTCTAAGTGATGACAGCCGTACCTGTCCTTGGCTCTTCTGGCACTGGCTTAGGAGTTGGACTTCAAACCCTCAGCCCTCCCTCTAAGATATATCTCTTGGCCCCATACCATCAGTACAAATTGCTACTAAAAACATCCTCCTTTGCAAGTGTATTTACGTAATATTTGGAATCACAGCTTGGTAAGCATATTGAAGATCGTTTTCCCAATTTTCTTATTACACAAATAAGAAGTTGATGCACTAAAAGTGGAAGAGTTTTGTCTACCATAATTCAGCTTTGGGATATGTAGATGGATCTCTTCCTGCGTCTCCAGAATATGCAAAATACTTACAGGACAGAATGGATGAAAACTCTACCTCGGTTCTAAGCATATCTTCTCCTTATTTGGATTAAAACCTTCTGGTAAGAAAAGAAAAAATATATATATATATGTGTGTATATATACACACATACATATACATATATATGCATTCATTTGTTGTTGTTTTTCTTAATTTGCTCATGCATGCTAATAAATTATGTCTAAAAATAGAATAAATACAAATCAATGTGCTCTGTGCATTAGTTACTTATTAGGTTTTGGGAAACAAGAGATAAAAAACTAGAGACCTCTTAATGCAGTCAAAAATACAAATAAATAAAAAGTCACTTACAACCCAAAGTGTGACTATCAATGGGGTAATCAGTGGTGTCAAATAGGAGGTTAACTGGGGACATCTAACTGTTTCTGCCTGGACTAATCTGCAAGAGTGTCTGGGGGAACAAAAAGCCTCTGTGACTTAGAAAGTAGGGGTAGGAGGGGAAAAGGTCTTCTACTTGGCTCAGATTATTTTTTTCCTCTAGTCCACTAAGAATACTGCGTTTTAAAATCATTTCCTTGATTCAAGTTCCTATTTCTCTTTATATTTTGTTTGTTTAAACCTCCTTTACTAAAATTTACTCTTCTTTCTCTATAGCTTCCCAACGTGATCGCCTTTCTCCCATCCCCCTGTACTTTTTCCCCTTGTACTAAATTAACTCCTCAGGTGAGGAAAAACTTTTGAAGTGCAGAGTTCTGCTTCCTGCTATTAAAAGATGTAATTAAAACAGCAAAGGTAGCAAGCATTTATGAGGTCAGCGTAGGGTCTCAGTGTTCCCTAAGGGCCCTGTCAGTCATCCTGAATCCTGCCCCTACCTGGAAACCCATGTCGGTTTAGTAAGGAAAGTGTTATACTTTTACTTTGCATGTTTCTCCTACTTCTTCCTTTCAGCTCTAACACTCTGAAACTACGATTACACAAAATAAAATAAAATAAAATAAAATAAAACAATAAAATGAAATAAAATTTAGGTTAACCAAAAGAAACTGGATCCTCTATTTCTAGTTATCAGAAGGAAATTTACAAATTTCTTATTTCCATTGCTTTATTCTCTTAAATGCTTTCTCTATTATTGCTAAATAAATAGAGATCTCTCACTTTTTCTACCTGTCTCAACCCTCATCAGGTACTTGTGAAAAAATCTCACTCTGATTATTCTCACACACGCAGAAAGTGTTTGGTTCTTCTATGGCTATCTGGAGCCTAGGTTAAAAAATTATGCCTATGTATGATTATAGAGGTAAGAGGGATAAAATTTAAGTATTTTCTTTTTATATTCATTCCTCTGTAAAAAACTAAAGCAATGAGGATCTAGGCACACGTGTATCCCTGAGAAAAGATTTCACATGTTGAATCCTGGGAAAAGACGTCTTTAAAATATTTTAAATGTTAAAACATGCAGATTTGACTTGGCTGTTAGATTTTGGATTTTATTTTATTAAATTTAAACCTGCATTAGCATTGTTTTAGATTTAGACAGTTTTCAAGACCCTGTTTCACATCCCTGATATAAGAGGCATGTATATGTGAAATAAAGTGTTCTGCGGAAGTTTGAATATGTCTTTTGCAAATATCCTGGGTCAAAGAAAATGCACAGACTTTATGAAATTATAATATAGGTTATATTTATAGTATTCTGAAAGACCAAAATTGTCAAAGCAAGAGCTTTGAAATCCTGATTGGCAGAAATTGTCACCTTCTTAAAGACTTACCCTACAACTTCTTATGCTCAGAAATAGTTTTCCTTTTTCTATTTTGTTTTCTTTTTTAAATGATGAACTATGGATCCTTCTCTTGTGTTGGCAACTGCTGCAGATACCATCATCCTGGCTTCAAGGCAGGGGTTGCTTTTCCAATGGTAGTTACTTAGTGTGACTAGAGTGTAACGCAGACTTTTCTTTCTATTACCCATAATACCCTGCAGGGACAAGGCTGCAAGCTATACTAAGACCATCAAAAGCCCAGGCATACCAGGCAAATAAGTTTCAAGAAGCAATAAATAGTGCAAATTTGGTTATGGTCAGAGCCTCAGTTTCAAATCTAAATCAGCATTCAAAGTTCCTGAAAAACTATTCAAGCTTACTGACATCTTCACTATTGTGAGCTTGCTTCTACTCTGTGAATGGATGCCACAGCAGGTGCAGGTCTATTCTACTTTTATTCCAGCCCCACTGACCACAACACACACACACACACACACACACACACACACACAAGTCCTCAAAAAAGAGACAGCGAGAGAGACAGAGGTCCATTTCCTTTACTCCAGTCTATTAATCTTTCTTAAGTCCTAATGTTTTATATCAGAATGGCCCTAGTCTGGGTATACTTAGAGGATGAATATTAACTTCCTCCATGAAAATCATGACACTCATCTATGGGAGTGTGGTTTTATCATTTGTTTCAAAAGCAGCACTTGACTAGAGTATTTTTATACATGCTCTACTGTTTAGTCTAAAATTCCCCAAGTGAGACATTTTAGCAATCTACTGTATATGTTCCTAGGTCAAGCACAGTCTAGCTACTTGCTACAGACTTCTCTCGCAGATACACAATCTCTCAGTAAACACAACTCAGCAGCTCTCAGAATTAATTAATTAAAATGAAATAAAAATGCTCCAAGAAAACCAGAACCCATAGAAACAAACCGCACACACACAAAATAGTTTGGAAATAGGATAGTTTAGTTCACTTTAAAAAGTTGTATTTCTTACCAAAAAGCAATAAAGTCAACATAGACAGAACTTTGCTAAAGTATATGCATAATTATTACAGAAAAATTTATATTTCAGTCTGCACCTTGTTCATTAATATTTCCTCCACTGGGCTCAGATTTTCATTCAGAATTAGCTTTTTTTTAACCTCATTAAGTGGGCCATGGTGTCAATTTATGGAGAGCAGAGGTACAGTCTTCAGATAAATTTGAGATTGCATCTCTTTAGAGGTAGAATCTTGGCTTCAGTCTGAACACCCTTTACAAACATGTAGGCATTAATTCAGAGGACTGCTCTGAAGCTCAAGAGATGGATGATTTAGGAGACTATTAGGCTTAATTCTCCTGACATTAAATTATTTTATTGAAAAATTTTCATGAACTCAAATTCACATTATTACGTCCTCTCTTCCCTTCCTCTCTCCCTCTCTTTCACACACACACACACCCTTTCATTCAGACATACTGAACATAGTTTATAAAGCAACGCCATAGTGAGAAAAGAAAAACAACCATTTGATAAATTATCAAATAAAATTAAAGCCAAATCTTGAGGAATTAATTCCATTCCTATACTTTGTTTTAACTTTCATTTTAAATTTGGGGGTACATGTACAAGTTATATAGGTAAATTGCATATCACTGGGTCTTGATGTACAGATTATTTCATCACTCAGTGATGAACTTAATACCCAATAGGTTCTTTTTCATCGTCTCCCTCTTCCCACCCTCAACCCTCAAGTAGGCCTGGGTGTCTGTTGATCTATTTTTTGTGTCCATGTGTATCATCATTTAGCTCCCACACTCCTAGACTCTTACAAAAGCTCTACTCTAACAAATAATTTTAATATAACAACAAGGTGCCAAGTCTTTTTTCATCTCTTGACCTCCTCATCTTCAATATGAAGATAGCAATGCCTAGCATATAGTAATTGTGTGTGCTCGGCACATGTCCCATCCAGGTGATGTTCTCATGAATTCTCTGGTATTTGGATTTTTAGGGCCAACATCTTGCCTAGACTCACTGACTACTTCTAATGGTGTAGGAATAGAAGGTATAGTAAGCTATATTTGCTCTTTTTTTTTGACTTTTGGAGAAAGGAATGTAGTTTGTTTTCCCTATCAAGATCATAAGGTCTACAATCTCTCTTACTGTCTTTCGAATACCACACAAGTATCTCCTTTTAATATCTTACTCTTATGAGAACTTCCCTATGCTCAGGAATGTGAAAGTGATCTTCCCCAAAATGCCCTGAGTAGCTCTGCTTCTGATATGTAAACCAGTGGTTCCTAAATATCTTATTCAGATATAAAGAGTTCTCAGTGCCTACTATGTATAATGACTTAAGGAAAACACATGGATATAAAAGAGCTTCTGCTGCCAGTCAATTCAAAATGTTGTGATCAAAACAGTTAACTATAACACATTGTCAGTATATTCTGGCAGTACAGACAGAGTTACTGTGAAAGCACTTTCAAACACAAGGAAACAACAGATTCTGTTTAGGTATTCAAGTAAGTTTAAAATTAATCAACATGCATATAATACAGATTTTTAAAAATGTATACAACTGAGAAAGTTCTAAAAATCCTTCTAATTTTACCTATGGCAAAAATGGTGCTCAAGGAAAAAAATATTACTCCTATGATCAGAAAGGAAATAACTGTTCGGTTGTTTACTGCATGCTTCCTCTTTGTATGTTGTAGCATTAACAACAAAGAAACACTGTGCGATGGTATTATTAATATTGTCCTCTAATTCCAGAAGTTCTAAAGCAAGGAATAATCATTCCTTCATTTACTCATTTACTCATTCGTTCATTCATTCACTGTTTTCTTGAATAAATATTTTCTTTCTGCCCATTGATGAATTTAATATGAGGCACAGTAGGCATGTAAGAAGGTAGAGAATAGGCAGAATTGCTTATAAAGCACGGAGTGTGTGTGTGTGCATGAAATAAATAAGAAAAATATAAAAATATAAAAAATGGTGTGGGGGAGGGTTTGGAAAGATTTTTTGGGTAGTATAGAGAAGTTTATTGTGGCTGGGGTCAAGAGAGGTCACAAGTAATACGTGAGCAATGAATCTTGACTGAAATATGGGAAGATAAGAGGAAATTCTTTACAGAGATGTTCTGGGGCAAGTAAGAGGAGGAAGCTATTTCTTGGAGCAGGAACACTTGATGGGGTATAGTATTATGGGCTACAATGTGCAGGCAAAGGAAGGAGGAAGAAAGACAACATAACATTGTCTTGAGTAATCATTATGCCTTTAATTGAGCACATTATTTTCTCAGTAATTGTTGGAGTTTAATCGTAGCATTACCCTTGAGGCTATGTCTTAGGGTTGAGGTCTTCCCTAGAACCTCTGCAGTGCCAGTATTATCTTTGTATCAAGAGTTCTTGATAATTTCTGCTCTTTGGAGGTAGAAGTGTCACCCATTAATGCCTTGTACGGTTCCCTTGCTTTTCTCTTTTCCCATGTACTCTTTGTAAAATAAACAAGTGCTCCCTATCTGTAGAGCCTCAGGAACCTTCTTACACACCTGGACAAAAAAATGAAATAAGTGAAATTAATCAGGAAGTTGAGCTGAACATTCTTTATTAGGCAGAAGCCATACCCTTGAAGTAGGCATTGTGTTCCCAAGTTCAGAAAATAGAATCTAGGGAAATAGGGTCTTCTTATGGTTATCAGGAAACAGTCCAGGATCTCAATGGTACTTGTGAGCCAGGGCATTAGCCACACCAGCCACCACCTTCTGATAGGCAGCCTGCATTTGTGGGGTGAATTCCTTGCCAAAGTTGCGGGCCAGCACACACACCAGCACATTGCCCAAGAGCTGCGGAGAAGAGGTAGGCAGATACATGCATATGGTTAACAGAGAAATAAAGACTGGCTTCTGAGAAACTGAGCCAACACCCATTTTTTTCTGCCCAAATCTTAGACAAAACTGATCCCCAGGTTATTCCCATCAGCATAAATAAGTACATATATGAATGCATACATATAACATATATCTATACACACACATCCTCTATGTACTTAACTAGCATGTAGTCTATATATGTACATATATGCTATATATGCTGTATAATACTATATACAAATTAATTCCAAATTAGTTTTAATTTTGTATGTGTATATAGCATATACAAATTAATTACTATAAACAGATTAATAGATACAAATTAATTGATTAATCAGTGTGATGATGGGCTGTCTCCTAGCAACGACTTCTGCCCCACCTCCAGTGTAACTGCCTAGTCTTTCATAATCAAATATTCACTTTCCTTTCCATTCCATTTACTACAGAATTTATAAAATTCCAATTATTCCTTATTGTAAAATGATTTATAGCCTCTAAAACAGTATTCTATGCCTCTCATCTTTGAGTTGGAGCCTCTCCCATACCCATGTGGAGAGACAAAAGGATTATTCTAAGTGCAGAATTAGCAGGTGAGAGCTGGTATGCATAATTTGAGTTGTTGTTAGAGAAGGAAAAATGAAGGGAGGGGGTTGGGAGAGAAAGACAGGATATTAAATAATTTAAAATAGCAAGATTGTGAGGAAGGAAAAAATGCAGAATATTTAAATAAAAAATTAACAAAATTTTAGAAGCATTAAATGATAAAATATAGTAAAATGACAAAAATGTGGGAGAAGAGCAGGTAGGTAAAAGAACCAAAATGTAAGATTAGAAAGTAAAAAGAGAAAAGTGAAGCATCTCCTGG" alternateAlleleVCF="A" />
      </Location>
      <OtherNameList>
        <Name>HBD87/HBB116 FUSION</Name>
        <Name>Hb Lepore-Boston-Washington</Name>
        <Name>Hemglobin Lepore Augusta</Name>
        <Name>Hemoglobin Pylos</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.5226570_5233984del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.5226570_5233984del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.5247800_5255214del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.5247800_5255214del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_000007.3" sequenceAccession="NG_000007" sequenceVersion="3" change="g.63632_71046del">
            <Expression>NG_000007.3:g.63632_71046del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1335" sequenceAccession="LRG_1335">
            <Expression>LRG_1335:g.14674_17980del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="744" DB="HBVAR" />
        <XRef ID="CA124670" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="142000.0020" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000011.10:g.5226570_5233984del AND Hemoglobin Lepore trait" Accession="RCV000016208" Version="10">
        <ClassifiedConditionList TraitSetID="4258">
          <ClassifiedCondition DB="MedGen" ID="C0472769">Hemoglobin Lepore trait</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1992-04-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NC_000011.10:g.5226570_5233984del AND multiple conditions" Accession="RCV000415449" Version="2">
        <ClassifiedConditionList TraitSetID="34125">
          <ClassifiedCondition DB="MedGen" ID="C0349705">Abnormal hemoglobin</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0002871">Anemia</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0239941">Persistence of hemoglobin F</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C4023137">Reduced beta/alpha synthesis ratio</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2014-09-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NC_000011.10:g.5226570_5233984del AND alpha Thalassemia" Accession="RCV001196231" Version="2">
        <ClassifiedConditionList TraitSetID="4863">
          <ClassifiedCondition DB="MedGen" ID="C0002312">alpha Thalassemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2016-01-01" NumberOfSubmissions="3" NumberOfSubmitters="2" DateCreated="2017-01-13" MostRecentSubmission="2023-10-07">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">1347969</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">13892631</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">14133899</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">1693293</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2442092</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">4625560</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">5660684</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">5964983</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="34125" Type="Finding" ContributesToAggregateClassification="true">
            <Trait ID="17169" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Anemia (disease)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Anemia</ElementValue>
                <XRef ID="Anemia/441" DB="Genetic Alliance" />
                <XRef ID="HP:0001903" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0002280" DB="MONDO" />
              </Name>
              <XRef ID="C0002871" DB="MedGen" />
              <XRef ID="MONDO:0002280" DB="MONDO" />
              <XRef Type="primary" ID="HP:0001903" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001926" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0003136" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0005509" DB="Human Phenotype Ontology" />
            </Trait>
            <Trait ID="29791" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Abnormal hemoglobin</ElementValue>
                <XRef ID="HP:0011902" DB="Human Phenotype Ontology" />
              </Name>
              <XRef ID="C0349705" DB="MedGen" />
              <XRef Type="primary" ID="HP:0011902" DB="Human Phenotype Ontology" />
            </Trait>
            <Trait ID="29793" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Persistence of hemoglobin F</ElementValue>
                <XRef ID="HP:0011904" DB="Human Phenotype Ontology" />
              </Name>
              <XRef ID="C0239941" DB="MedGen" />
              <XRef Type="primary" ID="HP:0011904" DB="Human Phenotype Ontology" />
            </Trait>
            <Trait ID="29795" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Reduced beta/alpha synthesis ratio</ElementValue>
                <XRef ID="HP:0011906" DB="Human Phenotype Ontology" />
              </Name>
              <XRef ID="C4023137" DB="MedGen" />
              <XRef Type="primary" ID="HP:0011906" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="4863" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6489" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">alpha Thalassemia</ElementValue>
                <XRef ID="Alpha-Thalassemia/333" DB="Genetic Alliance" />
                <XRef ID="68913001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">A-Thalassemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Alpha thalassemia spectrum</ElementValue>
                <XRef ID="MONDO:0011399" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Alpha-thalassemia (a-thalassemia) has two clinically significant forms: hemoglobin Bart hydrops fetalis (Hb Bart) syndrome (caused by deletion/inactivation of all four a-globin genes; --/--), and hemoglobin H (HbH) disease (most frequently caused by deletion/inactivation of three a-globin genes; --/-a). Hb Bart syndrome, the more severe form, is characterized by prenatal onset of generalized edema and pleural and pericardial effusions as a result of congestive heart failure induced by severe anemia. Extramedullary erythropoiesis, marked hepatosplenomegaly, and a massive placenta are common. Death usually occurs in the neonatal period. HbH disease has a broad phenotypic spectrum: although clinical features usually develop in the first years of life, HbH disease may not present until adulthood or may be diagnosed only during routine hematologic analysis in an asymptomatic individual. The majority of individuals have enlargement of the spleen (and less commonly of the liver), mild jaundice, and sometimes thalassemia-like bone changes. Individuals with HbH disease may develop gallstones and experience acute episodes of hemolysis in response to infections or exposure to oxidant drugs.</Attribute>
                <XRef ID="NBK1435" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="621" />
                <XRef ID="621" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301608</ID>
                <ID Source="BookShelf">NBK1435</ID>
              </Citation>
              <Citation Type="general" Abbrev="EMQN, 2014">
                <ID Source="PubMed">25052315</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2021">
                <ID Source="PubMed">17197616</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2009">
                <URL>https://www.acmg.net/PDFLibrary/HB-Screening-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Hb Screening (non-S), 2009</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Alpha-Thalassemia-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, FA + Barts Hb, Alpha (a) Thalassemia, 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2023">
                <URL>https://www.acmg.net/PDFLibrary/Alpha-Thalassemia-Barts-Present-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics Newborn Screening ACT sheet, FA + Barts present (unquantified), FAB, Alpha Thalassemia, 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2023">
                <URL>https://www.acmg.net/PDFLibrary/Alpha-Thalassemia-Barts-Present-Algorithm.pdf</URL>
                <CitationText>ACMG Algorithm, Hemoglobin FA + Barts: Unquantified Barts Alpha Thalassemia Screening Result (FAB), 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2023">
                <URL>https://www.acmg.net/PDFLibrary/Alpha-Thalassemia-Low-Moderate-Barts-Algorithm.pdf</URL>
                <CitationText>ACMG Algorithm, Hemoglobin FA + Barts: Low/Moderate Barts Alpha Thalassemia Screening Result (FAB2; FAB1), 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2023">
                <URL>https://www.acmg.net/PDFLibrary/Alpha-Thalassemia-Low-Moderate-Barts-ACT-Sheet.pdf</URL>
                <CitationText>ACMG ACT, FA + Low/Moderate Barts Hb, FAB2, FAB1 Alpha Thalassemia: Silent carrier and alpha thalassemia trait, 2023</CitationText>
              </Citation>
              <XRef ID="846" DB="Orphanet" />
              <XRef ID="C0002312" DB="MedGen" />
              <XRef ID="MONDO:0011399" DB="MONDO" />
              <XRef Type="MIM" ID="604131" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="4258" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="11533" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hemoglobin Lepore trait</ElementValue>
                <XRef ID="234387004" DB="SNOMED CT" />
              </Name>
              <Citation Type="general" Abbrev="EMQN, 2014">
                <ID Source="PubMed">25052315</ID>
              </Citation>
              <XRef ID="C0472769" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="36476" SubmissionDate="2017-12-12" DateLastUpdated="2023-10-07" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="142000.0020_HEMOGLOBIN LEPORE (BOSTON)" title="HBD, HBD87/HBB116 FUSION_HEMOGLOBIN LEPORE (BOSTON)" />
        <ClinVarAccession Accession="SCV000036476" DateUpdated="2023-10-07" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <ReplacedList>
          <Replaced Accession="SCV000036479" DateChanged="2014-08-13" Version="1" />
          <Replaced Accession="SCV000036478" DateChanged="2014-08-13" Version="1" />
          <Replaced Accession="SCV000036477" DateChanged="2014-08-13" Version="1" />
        </ReplacedList>
        <Classification DateLastEvaluated="1992-04-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Delta-beta fusion (delta 87 to beta 116) is the molecular lesion. Different hemoglobins Lepore show evidence that the crossover occurred at different sites: e.g., Hb Lepore (Washington) has the shift-over somewhere between amino acids at 87 and 116 (Labie et al., 1966). (It is impossible to position it more precisely because the delta and beta chains are identical between these residues.) Among 44 chromosomes carrying the Hb Lepore (Washington) hybrid gene, Lanclos et al. (1987) found 2 and possibly 3 different haplotypes. See Baglioni (1962), Fessas et al. (1962), Curtain (1964), and Ahern et al. (1972). Using maternal blood as a source for fetal cells in 3 pregnancies at risk for beta-thalassemia/hemoglobin Lepore disease, Camaschella et al. (1990) made a molecular diagnosis of hemoglobin Lepore-Boston in the fetus. Taking advantage of the PCR method for amplifying Lepore-specific DNA fragments in families in which Hb Lepore was inherited on the paternal side, they demonstrated in 2 cases and excluded in 1 the presence of this hemoglobinopathy in the fetus through the study of DNA from the maternal blood. This is one of the first instances of prenatal diagnosis by study of fetal cells in the maternal circulation. Fioretti et al. (1992) identified a hybrid delta-beta-globin gene in 40 families living in Abruzzo and Campania, which are on the east and west coast of Italy, respectively. In all cases the gene was of the Lepore-Boston type: it had the delta-globin sequence up to exon 2 codon 87 and had the beta-globin sequence from nucleotide 8 of IVS2. Between these 2 ends, the gene had 58 bp in common with the delta- and beta-globin genes. Fioretti et al. (1992) found that 12 of 12 genes from Abruzzo were of 1 haplotype, which was present in only 8 of 31 genes from Campania. The other Campania genes were all of another haplotype. DNA sequencing of homozygous subjects who showed the 'Abruzzo haplotype' had G at nucleotide 74 of IVS2, whereas those of the alternative haplotype had a T at that site. The geographic pattern as well as the molecular characteristics suggested to Fioretti et al. (1992) that Hb Lepore-Boston had had recurrent and multicentric origins.</Attribute>
              <Citation>
                <ID Source="PubMed">5964983</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">2442092</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">5660684</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">13892631</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">14133899</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">4625560</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">1693293</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">1347969</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HBD" />
          </GeneList>
          <Name>HBD, HBD87/HBB116 FUSION</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">HBD87/HBB116 FUSION</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="142000.0020" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">HEMOGLOBIN LEPORE (BOSTON)</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="962339" SubmissionDate="2016-11-12" DateLastUpdated="2023-10-07" DateCreated="2017-01-13">
        <ClinVarSubmissionID localKey="CMGVARID00231|HPO:HP:0011902;HP:0001903;HP:0011904;HP:0011906" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000492683" DateUpdated="2023-10-07" DateCreated="2017-01-13" Type="SCV" Version="2" SubmitterName="Centre for Mendelian Genomics, University Medical Centre Ljubljana" OrgID="505952" OrganizationCategory="clinic" OrgAbbreviation="CMG-UMCL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-09-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HBB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NG_000007.3:g.63632_71046del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="HP" ID="HP:0011902" />
          </Trait>
          <Trait Type="Finding">
            <XRef DB="HP" ID="HP:0001903" />
          </Trait>
          <Trait Type="Finding">
            <XRef DB="HP" ID="HP:0011904" />
          </Trait>
          <Trait Type="Finding">
            <XRef DB="HP" ID="HP:0011906" />
          </Trait>
        </TraitSet>
        <StudyDescription>Diagnostic exome sequencing variant classification from diagnostic exome sequencing programme</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>CMG_Slovenia_Submission_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2694862" SubmissionDate="2020-11-24" DateLastUpdated="2023-10-07" DateCreated="2020-07-04">
        <ClinVarSubmissionID localKey="NG_000007.3:g.63632_71046del|OMIM:604131" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001366781" DateUpdated="2023-10-07" DateCreated="2020-07-04" Type="SCV" Version="3" SubmitterName="Centre for Mendelian Genomics, University Medical Centre Ljubljana" OrgID="505952" OrganizationCategory="clinic" OrgAbbreviation="CMG-UMCL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-01-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant was classified as: Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NG_000007.3:g.63632_71046del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604131" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8622351</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="962339" TraitType="Finding" MappingType="XRef" MappingValue="HP:0011906" MappingRef="HP">
        <MedGen CUI="C4023137" Name="Reduced beta/alpha synthesis ratio" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="962339" TraitType="Finding" MappingType="XRef" MappingValue="HP:0011902" MappingRef="HP">
        <MedGen CUI="C0349705" Name="Abnormal hemoglobin" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2694862" TraitType="Disease" MappingType="XRef" MappingValue="604131" MappingRef="OMIM">
        <MedGen CUI="C0002312" Name="alpha Thalassemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="962339" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001903" MappingRef="HP">
        <MedGen CUI="C0002871" Name="Anemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="962339" TraitType="Finding" MappingType="XRef" MappingValue="HP:0011904" MappingRef="HP">
        <MedGen CUI="C0239941" Name="Persistence of hemoglobin F" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="36476" TraitType="Disease" MappingType="Name" MappingValue="HEMOGLOBIN LEPORE (BOSTON)" MappingRef="Preferred">
        <MedGen CUI="C0472769" Name="Hemoglobin Lepore trait" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

